|
|
|
|
|
When Software Becomes Part Of The Medicine
|
|
By Andrey Meshcheryakov, Recombinators
|
Software is no longer just a support tool; it is central to real-world efficacy, transforming combination products by optimizing dosing, adherence, and technique.
|
|
|
|
The QMSR's Hidden ROI: LATAM's Device Trial Advantage
|
|
By Julio G. Martinez-Clark, bioaccess
|
The FDA's new QMSR quietly created a harmonized quality framework between the U.S. and Latin America. With high recruitment performance and low cost, conducting medtech trials in the region has key benefits.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Med Device Online: |
|
|
|
|
